Q2 2020 Holdings
Filed 2020-08-12 | 19 holdings | $1.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-08-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $990.0K | 364,132 | 79.5% |
| Repare Therapeutics Inc(RPTX)A | COM | 760273102 | $77.7K | 2,503,408 | 6.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $74.9K | 2,305,994 | 6.0% |
| Akouos IncA | COM | 00973J101 | $21.9K | 974,985 | 1.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $21.7K | 579,744 | 1.7% |
| Larimar Therapeutics Inc(LRMR)A | COM | 517125100 | $19.5K | 1,515,148 | 1.6% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $17.6K | 2,931,185 | 1.4% |
| Precision Biosciences Inc | COM | 74019P108 | $8.0K | 960,040 | 0.6% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $4.0K | 544,281 | 0.3% |
| Kezar Life Sciences Inc | COM | 49372L100 | $1.8K | 340,973 | 0.1% |
| Myokardia Inc | COM | 62857M105 | $1.3K | 13,500 | 0.1% |
| Livongo Health Inc(LVGO) | COM | 539183103 | $1.1K | 15,000 | 0.1% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $1.1K | 44,000 | 0.1% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $1.0K | 50,000 | 0.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $1.0K | 13,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $936 | 12,000 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $821 | 13,000 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $488 | 8,000 | 0.0% |
| Unum Therapeutics Inc | COM | 903214104 | $433 | 940,805 | 0.0% |